Comparative study of piroxicam and indomethacin retard in osteoarthritis

Eur J Rheumatol Inflamm. 1983;6(1):106-12.

Abstract

Indomethacin retard and piroxicam were compared in an open, randomized, parallel study in the treatment of osteoarthritis. Improvement of the symptoms of the disease was highly significant for both drugs. There was no statistical difference between the two drugs in terms of efficacy. Number and duration of side effects were significantly lower with piroxicam than with indomethacin retard. Piroxicam was administered once a day. Indomethacin retard was always (43% of the cases) or sometimes (14%) given twice daily.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Delayed-Action Preparations
  • Female
  • Half-Life
  • Humans
  • Indomethacin / therapeutic use*
  • Male
  • Middle Aged
  • Osteoarthritis / drug therapy*
  • Pain / drug therapy
  • Piroxicam
  • Thiazines / adverse effects
  • Thiazines / therapeutic use*
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Delayed-Action Preparations
  • Thiazines
  • Piroxicam
  • Indomethacin